Search

Your search keyword '"Gada, Hemal"' showing total 374 results
Start Over Author "Gada, Hemal"
374 results on '"Gada, Hemal"'

4. Use and performance of the evolut FX transcatheter aortic valve system

Author

Bajwa, Tanvir, Attizzani, Guilherme F., Gada, Hemal, Chetcuti, Stanley J., Williams, Mathew R., Ahmed, Mustafa, Petrossian, George A., Saybolt, Matthew D., Allaqaband, Suhail Q., Merhi, William M., Stoler, Robert C., Bezerra, Hiram, Mahoney, Paul, Wu, Willis, Jumper, Robert, Lambrecht, Larry, and Tang, Gilbert H.L.

Published
2024
Full Text
View/download PDF

6. 1-Year Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement: Intrepid TMVR Early Feasibility Study Results

Author

Zahr, Firas, Song, Howard K., Chadderdon, Scott, Gada, Hemal, Mumtaz, Mubashir, Byrne, Timothy, Kirshner, Merick, Sharma, Samin, Kodali, Susheel, George, Isaac, Merhi, William, Yarboro, Leora, Sorajja, Paul, Bapat, Vinayak, Bajwa, Tanvir, Weiss, Eric, Thaden, Jeremy J., Gearhart, Elizabeth, Lim, Scott, Reardon, Michael, Adams, David, Mack, Michael, and Leon, Martin B.

Published
2023
Full Text
View/download PDF

7. 1-Year Outcomes From the CLASP IID Randomized Trial for Degenerative Mitral Regurgitation

Author

Zahr, Firas, Smith, Robert L., Gillam, Linda D., Chadderdon, Scott, Makkar, Raj, von Bardeleben, Ralph Stephan, Ruf, Tobias Friedrich, Kipperman, Robert M., Rassi, Andrew N., Szerlip, Molly, Goldman, Scott, Inglessis-Azuaje, Ignacio, Yadav, Pradeep, Lurz, Philipp, Davidson, Charles J., Mumtaz, Mubashir, Gada, Hemal, Kar, Saibal, Kodali, Susheel K., Laham, Roger, Hiesinger, William, Fam, Neil P., Keßler, Mirjam, O’Neill, William W., Whisenant, Brian, Kliger, Chad, Kapadia, Samir, Rudolph, Volker, Choo, Joseph, Hermiller, James, Morse, Michael A., Schofer, Niklas, Gafoor, Sameer, Latib, Azeem, Mahoney, Paul, Kaneko, Tsuyoshi, Shah, Pinak B., Riddick, John A., Muhammad, Kamran I., Boekstegers, Peter, Price, Matthew J., Praz, Fabien, Koulogiannis, Konstantinos, Marcoff, Leo, Hausleiter, Jörg, and Lim, D. Scott

Published
2023
Full Text
View/download PDF

9. Feasibility of Coronary Access Following Redo-TAVR for Evolut Failure: A Computed Tomography Simulation Study

Author

Tang, Gilbert H.L., Spencer, Julianne, Rogers, Toby, Grubb, Kendra J., Gleason, Patrick, Gada, Hemal, Mahoney, Paul, Dauerman, Harold L., Forrest, John K., Reardon, Michael J., Blanke, Philipp, Leipsic, Jonathon A., Abdel-Wahab, Mohamed, Attizzani, Guilherme F., Puri, Rishi, Caskey, Michael, Chung, Christine J., Chen, Ying-Hwa, Dudek, Dariusz, Allen, Keith B., Chhatriwalla, Adnan K., Htun, Wah Wah, Blackman, Daniel J., Tarantini, Giuseppe, Zhingre Sanchez, Jorge, Schwartz, Greta, Popma, Jeffrey J., and Sathananthan, Janarthanan

Published
2023
Full Text
View/download PDF

10. Transcatheter Left Ventricular Restoration in Patients With Heart Failure

Author

Hamid, NADIRA, JORDE, ULRICH P., REISMAN, MARK, LATIB, AZEEM, LIM, D. SCOTT, JOSEPH, SUSAN M., KURLIANSKAYA, ALENA, POLONETSKY, OLEG, NEUZIL, PETR, REDDY, VIVEK, FOERST, JASON, GADA, HEMAL, GRUBB, KENDRA J., SILVA, GUILHERME, KEREIAKES, DEAN, SHREENIVAS, SATYA, PINNEY, SEAN, DAVIDAVICIUS, GIEDRIUS, SORAJJA, PAUL, BOEHMER, JOHN P., KLEBER, FRANZ X., PERIER, PATRICK, VAN MIEGHEM, NICOLAS M., DUMONTEIL, NICOLAS, LEON, MARTIN B., and BURKHOFF, DANIEL

Published
2023
Full Text
View/download PDF

11. Clinical Impact of Standardized TAVR Technique and Care Pathway: Insights From the Optimize PRO Study

Author

Grubb, Kendra J., Gada, Hemal, Mittal, Suneet, Nazif, Tamim, Rodés-Cabau, Josep, Fraser, Douglas G.W., Lin, Lang, Rovin, Joshua D., Khalil, Ramzi, Sultan, Ibrahim, Gardner, Blake, Lorenz, David, Chetcuti, Stanley J., Patel, Nainesh C., Harvey, James E., Mahoney, Paul, Schwartz, Brian, Jafar, Zubair, Wang, John, Potluri, Srinivasa, Vora, Amit N., Sanchez, Carlos, Corrigan, Amy, Li, Shuzhen, and Yakubov, Steven J.

Published
2023
Full Text
View/download PDF

13. Leaflet modification before transcatheter aortic valve implantation in patients at risk for coronary obstruction: the ShortCut study

Author

Dvir, Danny, primary, Tchétché, Didier, additional, Leon, Martin B, additional, Généreux, Philippe, additional, Seguy, Benjamin, additional, Makkar, Raj, additional, Pibarot, Philippe, additional, Gada, Hemal, additional, Nazif, Tamim, additional, Hildick-Smith, David, additional, Kempfert, Jörg, additional, Dumonteil, Nicolas, additional, Unbehaun, Axel, additional, Modine, Thomas, additional, Whisenant, Brian, additional, Caussin, Christophe, additional, Conradi, Lenard, additional, Waggoner, Thomas, additional, Mishell, Jacob M, additional, Chetcuti, Stanley J, additional, Kar, Saibal, additional, Rinaldi, Michael J, additional, Szerlip, Molly, additional, Ramana, Ravi K, additional, Blackman, Daniel J, additional, Ben-Dor, Itsik, additional, Kornowski, Ran, additional, Waksman, Ron, additional, Gerckens, Ulrich, additional, Denti, Paolo, additional, Kukucka, Marian, additional, Ternacle, Julien, additional, Skaf, Sabah, additional, Kovac, Jan, additional, Jilaihawi, Hasan, additional, Patel, Vivek, additional, Jubeh, Rami, additional, Abdel-Wahab, Mohamed, additional, and Kodali, Susheel, additional

Published
2024
Full Text
View/download PDF

14. Randomized Comparison of Transcatheter Edge-to-Edge Repair for Degenerative Mitral Regurgitation in Prohibitive Surgical Risk Patients

Author

Lim, D. Scott, Smith, Robert L., Gillam, Linda D., Zahr, Firas, Chadderdon, Scott, Makkar, Raj, von Bardeleben, Ralph Stephan, Kipperman, Robert M., Rassi, Andrew N., Szerlip, Molly, Goldman, Scott, Inglessis-Azuaje, Ignacio, Yadav, Pradeep, Lurz, Philipp, Davidson, Charles J., Mumtaz, Mubashir, Gada, Hemal, Kar, Saibal, Kodali, Susheel K., Laham, Roger, Hiesinger, William, Fam, Neil P., Keßler, Mirjam, O’Neill, William W., Whisenant, Brian, Kliger, Chad, Kapadia, Samir, Rudolph, Volker, Choo, Joseph, Hermiller, James, Morse, Michael A., Schofer, Niklas, Gafoor, Sameer, Latib, Azeem, Koulogiannis, Konstantinos, Marcoff, Leo, and Hausleiter, Jörg

Published
2022
Full Text
View/download PDF

15. 2-Year Outcomes After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients

Author

Forrest, John K., Deeb, G. Michael, Yakubov, Steven J., Rovin, Joshua D., Mumtaz, Mubashir, Gada, Hemal, O’Hair, Daniel, Bajwa, Tanvir, Sorajja, Paul, Heiser, John C., Merhi, William, Mangi, Abeel, Spriggs, Douglas J., Kleiman, Neal S., Chetcuti, Stanley J., Teirstein, Paul S., Zorn, George L., III, Tadros, Peter, Tchétché, Didier, Resar, Jon R., Walton, Antony, Gleason, Thomas G., Ramlawi, Basel, Iskander, Ayman, Caputo, Ronald, Oh, Jae K., Huang, Jian, and Reardon, Michael J.

Published
2022
Full Text
View/download PDF

17. 3-Year Outcomes From the Evolut Low Risk TAVR Bicuspid Study.

Author

Zahr, Firas, Ramlawi, Basel, Reardon, Michael J., Deeb, G. Michael, Yakubov, Steven J., Song, Howard K., Kleiman, Neal S., Chetcuti, Stanley J., Gada, Hemal, Mumtaz, Mubashir, Leung, Stephane, Merhi, William, Rovin, Joshua D., DeFrain, Michael, Muppala, Murali, Kauten, James, Rajagopal, Vivek, Huang, Jiang, Ito, Saki, and Forrest, John K.

Abstract

Outcomes from transcatheter aortic valve replacement (TAVR) in low–surgical risk patients with bicuspid aortic stenosis beyond 2 years are limited. This study aimed to evaluate 3-year clinical and echocardiographic outcomes from the Evolut Low Risk Bicuspid Study. The Evolut Low Risk Bicuspid Study is a prospective, multicenter, single-arm study conducted in 25 U.S. centers. Patients with severe aortic stenosis at low surgical risk with bicuspid aortic valve anatomy (all subtypes) underwent TAVR with a self-expanding, supra-annular Evolut R or PRO (Medtronic) bioprosthesis. An independent clinical events committee adjudicated all deaths and endpoint-related adverse events, and a central echocardiographic core laboratory assessed hemodynamic endpoints. An attempted implant was performed in 150 patients from December 2018 to October 2019. The mean age was 70.3 ± 5.5 years, 48% (72/150) of the patients were women, and the mean Society of Thoracic Surgeons Predicted Risk of Mortality score was 1.3% (Q1-Q3: 0.9%-1.7%). Sievers type 1 was the dominant bicuspid morphology (90.7%, 136/150). The Kaplan-Meier rates of all-cause mortality or disabling stroke were 1.3% (95% CI: 0.3%-5.3%) at 1 year, 3.4% (95% CI: 1.4%-8.1%) at 2 years, and 4.1% (95% CI: 1.6%-10.7%) at 3 years. The incidence of new permanent pacemaker implantation was 19.4% (95% CI: 12.4%-29.6%) at 3 years. There were no instances of moderate or severe paravalvular aortic regurgitation at 2 and 3 years after TAVR. The 3-year results from the Evolut Low Risk Bicuspid Study demonstrate low rates of all-cause mortality or disabling stroke and favorable hemodynamic performance. [Display omitted] [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

18. First Experience With Amulet in the United States

Author

Alkhouli, Mohamad, primary, Freeman, James V., additional, Ellis, Christopher R., additional, Shah, Atman P., additional, Gada, Hemal, additional, Coylewright, Megan, additional, Lo, Monica, additional, Makkar, Akash, additional, Agarwal, Himanshu, additional, and Lakkireddy, Dhanunjaya, additional

Published
2024
Full Text
View/download PDF

22. Quality of Life 5 Years Following Transfemoral TAVR or SAVR in Intermediate Risk Patients.

Author

Kleiman, Neal S., Van Mieghem, Nicolas M., Reardon, Michael J., Gada, Hemal, Mumtaz, Mubashir, Olsen, Peter Skov, Heiser, John, Merhi, William, Chetcuti, Stanley, Deeb, G. Michael, Chawla, Atul, Kiaii, Bob, Teefy, Patrick, Chu, Michael W.A., Yakubov, Steven J., Windecker, Stephan, Althouse, Andrew D., and Baron, Suzanne J.

Abstract

Symptomatic patients with severe aortic stenosis (AS) at high risk for surgical aortic valve replacement (SAVR) sustain comparable improvements in health status over 5 years after transcatheter aortic valve replacement (TAVR) or SAVR. Whether a similar long-term benefit is observed among intermediate-risk AS patients is unknown. The purpose of this study was to assess health status outcomes through 5 years in intermediate risk patients treated with a self-expanding TAVR prosthesis or SAVR using data from the SURTAVI (Surgical Replacement and Transcatheter Aortic Valve Implantation) trial. Intermediate-risk patients randomized to transfemoral TAVR or SAVR in the SURTAVI trial had disease-specific health status assessed at baseline, 30 days, and annually to 5 years using the Kansas City Cardiomyopathy Questionnaire (KCCQ). Health status was compared between groups using fixed effects repeated measures modelling. Of the 1,584 patients (TAVR, n = 805; SAVR, n = 779) included in the analysis, health status improved more rapidly after TAVR compared with SAVR. However, by 1 year, both groups experienced large health status benefits (mean change in KCCQ-Overall Summary Score (KCCQ-OS) from baseline: TAVR: 20.5 ± 22.4; SAVR: 20.5 ± 22.2). This benefit was sustained, albeit modestly attenuated, at 5 years (mean change in KCCQ-OS from baseline: TAVR: 15.4 ± 25.1; SAVR: 14.3 ± 24.2). There were no significant differences in health status between the cohorts at 1 year or beyond. Similar findings were observed in the KCCQ subscales, although a substantial attenuation of benefit was noted in the physical limitation subscale over time in both groups. In intermediate-risk AS patients, both transfemoral TAVR and SAVR resulted in comparable and durable health status benefits to 5 years. Further research is necessary to elucidate the mechanisms for the small decline in health status noted at 5 years compared with 1 year in both groups. (Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement [SURTAVI]; NCT01586910) [Display omitted] [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

23. Propensity-Matched Comparison of Evolut-R Transcatheter Aortic Valve Implantation With Surgery in Intermediate-Risk Patients (from the SURTAVI Trial)

Author

Yakubov, Steven J., Van Mieghem, Nicolas M., Reardon, Michael J., Serruys, Patrick W., Gada, Hemal, Mumtaz, Mubashir, Deeb, G. Michael, Kodali, Susheel, George, Isaac, Windecker, Stephan, Kleiman, Neal, Chetcuti, Stanley J., Sanchez, Carlos, Dauerman, Harold L., Li, Shuzhen, and Popma, Jeffrey J.

Published
2020
Full Text
View/download PDF

24. Complete 2-Year Results Confirm Bayesian Analysis of the SURTAVI Trial

Author

Sorajja, Paul, Sun, Benjamin, Agarwal, Himanshu, Langdon, Thomas, den Heijer, Peter, Bentala, Mohamed, O’Hair, Daniel, Bajwa, Tanvir, Byrne, Timothy, Caskey, Michael, Paulus, Basil, Garrett, Edward, Jr., Stoler, Robert, Hebeler, Robert, Popma, Jeffrey J., Khabbaz, Kamal, Lim, David Scott, Bladergroen, Mark, Fail, Peter, Feinberg, Edgar, II, Rinaldi, Michael, Skipper, Eric, Chawla, Atul, Hockmuth, David, Makkar, Raj, Cheng, Wen, Kodali, Susheel, George, Isaac, Aji, Janah, Bowen, Frank, Schreiber, Theodore, Henry, Scott, Hengstenberg, Christian, Bleiziffer, Sabine, Harrison, J. Kevin, Hughes, Chad, Joye, James, Gaudiani, Vincent, Babaliaros, Vasilis, Thourani, Vinod, van Mieghem, Nicolas, Kappetein, A. Pieter, Dauerman, Harold, Schmoker, Joseph, Skelding, Kimberly, Casale, Alfred, Kovac, Jan, Spyt, Tomasz, Seshiah, Puvi, Smith, J. Michael, McKay, Raymond, Hagberg, Robert, Matthews, Ray, Starnes, Vaughn, O’Neill, William, Paone, Gaetano, Hernandez García, Jose Maria, Such, Miguel, Morís de la Tassa, Cesar, Llosa Cortina, Juan Carlos, Windecker, Stephan, Carrel, Thierry, Whisenant, Brian, Doty, John, Resar, Jon, Conte, John, Aharonian, Vicken, Pfeffer, Thomas, Rück, Andreas, Corbascio, Matthias, Blackman, Daniel, Kaul, Pankaj, Kliger, Chad, Brinster, Derek, Teefy, Patrick, Kiaii, Bob, Leya, Ferdinand, Bakhos, Mamdouh, Sandhu, Gurpreet, Pochettino, Alberto, Piazza, Nicolo, de Varennes, Benoit, van Boven, Ad, Boonstra, Piet, Waksman, Ron, Bafi, Ammar, Asgar, Anita, Cartier, Raymond, Kipperman, Robert, Brown, John, Lin, Lang, Rovin, Joshua, Sharma, Samin, Adams, David, Katz, Stanley, Hartman, Alan, Al-Jilaihawi, Hasanian, Williams, Mathew, Crestanello, Juan, Lilly, Scott, Ghani, Mohammad, Bodenhamer, Robert Mark, Rajagopal, Vivek, Kauten, James, Mumtaz, Mumbashir, Bachinsky, Williams, Nickenig, Georg, Welz, Armin, Søndergaard, Lars, Olsen, Peter Skov, Yakubov, Steven, Watson, Daniel, Chhatriwalla, Adnan, Allen, Keith, Teirstein, Paul, Tyner, Jeffrey, Mahoney, Paul, Newton, Joseph, Merhi, William, Keiser, John, Yeung, Alan, Miller, Craig, ten Berg, Jurriën, Heijmen, Robin, Petrossian, George, Robinson, Newell, Brecker, Stephen, Jahangiri, Marjan, Davis, Thomas, Batra, Sanjay, Hermiller, James, Heimansohn, David, Radhakrishnan, Sam, Fremes, Stephen, Maini, Brijeshwar, Bethea, Brian, Brown, David, Ryan, William, Reardon, Michael, Kleiman, Neal, Spies, Christian, Lau, Jeffrey, Herrmann, Howard, Bavaria, Joseph, Horlick, Eric, Feindel, Chris, Neumann, Franz-Josef, Beyersdorf, Friedhelm, Binder, Roland, Maisano, Francesco, Costa, Marco, Markowitz, Alan, Tadros, Peter, Zorn, George, III, de Marchena, Eduardo, Salerno, Tomas, Chetcuti, Stanley, Deeb, G. Michael, Labinz, Marino, Ruel, Marc, Sup Lee, Joon, Gleason, Thomas, Ling, Frederick, Knight, Peter, Robbins, Mark, Ball, Stephen, Giacomini, John, Burdon, Thomas, Applegate, Robert, Kon, Neal, Schwartz, Richard, Schubach, Scott, Forrest, John, Mangi, Abeel, Van Mieghem, Nicolas M., Yakubov, Steven J., Serruys, Patrick W., Mumtaz, Mubashir, Gada, Hemal, Kleiman, Neal S., Oh, Jae K., Kappetein, Arie Pieter, Chang, Yanping, Mugglin, Andrew S., and Reardon, Michael J.

Published
2020
Full Text
View/download PDF

29. National Variability in Pacemaker Implantation Rate Following TAVR: Insights From the STS/ACC TVT Registry.

Author

Vora, Amit N., Gada, Hemal, Manandhar, Pratik, Kosinski, Andrezej, Kirtane, Ajay, Nazif, Tamim, Reardon, Michael, Kodali, Susheel, Cohen, David J., Thourani, Vinod, Sherwood, Matthew, Julien, Howard, and Vemulapalli, Sreekanth

Abstract

Although permanent pacemaker (PPM) implantation is a common complication of transcatheter aortic valve replacement (TAVR), hospital variation and change in PPM implantation rates are ill defined. The aim of this study was to determine hospital-level variation and temporal trends in the rate of PPM implantation following TAVR. Using the American College of Cardiology/Society of Thoracic Surgeons TVT (Transcatheter Valve Therapy) Registry, temporal changes in variation of in-hospital and 30-day PPM implantation were determined among 184,452 TAVR procedures across 653 sites performed from 2016 to 2020. The variation in PPM implantation adjusted for valve type by annualized TAVR volume was determined, and characteristics of sites below, within, and above the 95% boundary were identified. A series of stepwise multivariable hierarchical models were then fit, and the median OR was used to measure variation in pacemaker rates among sites. From 2016 to 2020, the overall rate of PPM implantation was 11.3%, with wide variation across sites (range: 0%-36.4%); rates trended lower over time. Adjusted for annualized volume, there were 34 sites with PPM implantation rates above the 95th percentile CI and 28 with rates below, with wide variation among the remaining sites. After adjusting for patient-level covariates, there was variation among sites in the probability of PPM implantation (median OR: 1.39; 95% CI: 1.35-1.43, P < 0.001); although some of the variation was explained by the addition of valve type, residual variation in PPM implantation rates persisted in additional models incorporating site-level covariates (annualized volume, region, teaching status, hospital beds, etc). Although PPM implantation rates have decreased over time, substantial site-level variation remains even after accounting for observed patient characteristics and site-level factors. As there are numerous outlier sites both above and below the 95% confidence limit, dissemination of best practices from high-performing sites to low-performing sites and guideline-based education may be important quality improvement initiatives to reduce rates of this common complication. [Display omitted] [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

31. TAVR in Intermediate-Risk Patients: 5-Year Outcomes From the SURTAVI Continued Access Study

Author

Mahoney, Paul, primary, Newton, Joseph, additional, Gada, Hemal, additional, Mumtaz, Mubashir, additional, Williams, Mathew, additional, Waksman, Ron, additional, Bafi, Ammar, additional, Fail, Peter, additional, Netherland, Donald, additional, Davis, Thomas, additional, Batra, Sanjay, additional, Chhim, Rothy, additional, Verdoliva, Sarah, additional, and Reardon, Michael J., additional

Published
2023
Full Text
View/download PDF

33. LB-8 | Performance and Use of the Evolut FX Transcatheter Aortic Valve System: Updated Results from the Evolut FX Limited Market Release Clinical Survey

Author

Bajwa, Tanvir K., primary, Attizzani, Guilherme, additional, Gada, Hemal, additional, Chetcuti, Stanley J., additional, Williams, Mathew Rulon, additional, Ahmed, Mustafa, additional, Petrossian, George A., additional, Saybolt, Matthew Douglas, additional, Lambrecht, Larry, additional, and Tang, Gilbert, additional

Published
2023
Full Text
View/download PDF

34. 3-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis

Author

Forrest, John K., primary, Deeb, G. Michael, additional, Yakubov, Steven J., additional, Gada, Hemal, additional, Mumtaz, Mubashir A., additional, Ramlawi, Basel, additional, Bajwa, Tanvir, additional, Teirstein, Paul S., additional, DeFrain, Michael, additional, Muppala, Murali, additional, Rutkin, Bruce J., additional, Chawla, Atul, additional, Jenson, Bart, additional, Chetcuti, Stanley J., additional, Stoler, Robert C., additional, Poulin, Marie-France, additional, Khabbaz, Kamal, additional, Levack, Melissa, additional, Goel, Kashish, additional, Tchétché, Didier, additional, Lam, Ka Yan, additional, Tonino, Pim A.L., additional, Ito, Saki, additional, Oh, Jae K., additional, Huang, Jian, additional, Popma, Jeffrey J., additional, Kleiman, Neal, additional, Reardon, Michael J., additional, Sorajja, Paul, additional, Byrne, Timothy, additional, Kirshner, Merick, additional, Crouch, John, additional, Coselli, Joseph, additional, Silva, Guilherme, additional, Hebeler, Robert, additional, Stoler, Robert, additional, Islam, Ashequl, additional, Rousou, Anthony, additional, Bladergroen, Mark, additional, Fail, Peter, additional, Netherland, Donald, additional, Tonino, W.A.L., additional, Sudre, Arnaud, additional, Berthoumieu, Pierre, additional, Khalili, Houman, additional, Hughes, G. Chad, additional, Harrison, J Kevin, additional, De, Ajanta, additional, Tsau, Pei, additional, van Mieghem, Nicolas M., additional, Larbalestier, Robert, additional, Yong, Gerald, additional, Agarwal, Shikhar, additional, Martin, William, additional, Park, Steven, additional, Reardon, Michael, additional, Mohammadi, Siamak, additional, Rodes-Cabau, Josep, additional, Sparling, Jeffrey, additional, Elkins, C. Craig, additional, Ganzel, Brian, additional, Matthews, Ray V., additional, Starnes, Vaughn A., additional, Ando, Kenji, additional, Chevalier, Bernard, additional, Farge, Arnaud, additional, Combs, William, additional, Bagur, Rodrigo, additional, Chu, Michael, additional, Fontana, Gregory, additional, Dev, Visha, additional, Leya, Ferdinand, additional, Tuchek, J. Michael, additional, Inglessis, Ignacio, additional, Jassar, Arminder, additional, Piazza, Nicolo, additional, Lacappelle, Kevin, additional, Steinberg, Daniel, additional, Katz, Marc, additional, Wang, John, additional, Kozina, Joseph, additional, Slachman, Frank, additional, Merritt, Robert, additional, Jensen, Bart, additional, Alvarez, Jorge, additional, Gooley, Robert, additional, Smith, Julian, additional, Ibrahim, Reda, additional, Cartier, Raymond, additional, Rovin, Joshua, additional, Fujita, Tomoyuki, additional, Rutkin, Bruce, additional, Yakubov, Steven, additional, Song, Howard, additional, Zahr, Firas, additional, Miyagawa, Shigeru, additional, Rajagopal, Vivek, additional, Kauten, James, additional, Mumtaz, Mubashir, additional, Bhindi, Ravinay, additional, Brady, Peter, additional, Batra, Sanjay, additional, Davis, Thomas, additional, Iskander, Ayman, additional, Heimansohn, David, additional, Hermiller, James, additional, Takamisawa, Itaru, additional, Haldis, Thomas, additional, Yamazaki, Seiji, additional, Teirstein, Paul, additional, Tada, Norio, additional, Saito, Shigeru, additional, Merhi, William, additional, Leung, Stephane, additional, Muller, David, additional, Heijmen, Robin, additional, Petrossian, George, additional, Robinson, Newell, additional, Knight, Peter, additional, Ling, Frederick, additional, Radhakrishnan, Sam, additional, Fremes, Stephen, additional, Lehr, Eric, additional, Gafoor, Sameer, additional, Noel, Thomas, additional, Walton, Antony, additional, Resar, Jon, additional, Adams, David, additional, Sharma, Samin, additional, Lilly, Scott, additional, Tadros, Peter, additional, Zorn, George, additional, Dauerman, Harold, additional, Ittleman, Frank, additional, Horlick, Erik, additional, Feindel, Chris, additional, Welt, Frederick, additional, Sharma, Vikas, additional, Markowitz, Alan, additional, Carroll, John, additional, Fullerton, David, additional, Griffith, Bartley, additional, Gupta, Anuj, additional, de Marchena, Eduardo, additional, Salerno, Tomas, additional, Chetcuti, Stanley, additional, Sultan, Ibrahim, additional, Pasupati, Sanjeevan, additional, Kon, Neal, additional, Zhao, David, additional, and Forrest, John, additional

Published
2023
Full Text
View/download PDF

35. Impact of aortic valve replacement in symptomatic low-risk patients with less than severe aortic stenosis

Author

Ito, Saki, primary, Laham, Roger, additional, Nkomo, Vuyisile T, additional, Forrest, John K, additional, Reardon, Michael J, additional, Little, Stephen H, additional, Mumtaz, Mubashir, additional, Gada, Hemal, additional, Bajwa, Tanvir, additional, Langholz, David, additional, Heiser, John, additional, Chawla, Atul, additional, Jenson, Bart, additional, Attizanni, Guilherme, additional, Markowitz, Alan H, additional, Huang, Jian, additional, and Oh, Jae K, additional

Published
2023
Full Text
View/download PDF

37. COMPUTED TOMOGRAPHY TO ASSESS FEASIBILITY OF CORONARY ACCESS FOLLOWING BALLOON-EXPANDABLE VALVE IMPLANTATION WITHIN A SUPRA-ANNULAR TRANSCATHETER VALVE

Author

Rogers, Toby, primary, Spencer, Julianne, additional, Tang, Gilbert Hin-Lung, additional, Grubb, Kendra Janel, additional, Gleason, Patrick, additional, Gada, Hemal, additional, Mahoney, Paul D., additional, Dauerman, Harold L., additional, Forrest, John K., additional, Reardon, Michael J., additional, Abdel-Wahab, Mohamed, additional, Puri, Rishi, additional, Attizzani, Guilherme, additional, Caskey, Michael, additional, Chung, Christine, additional, Chen, Ying-Hwa, additional, Htun, Wah Wah, additional, Sanchez, Jorge Zhingre, additional, Schwartz, Greta, additional, Popma, Jeffrey J., additional, and Sathananthan, Janarthanan, additional

Published
2023
Full Text
View/download PDF

38. BIOPROSTHETIC VALVE FRACTURE IN PATIENTS UNDERGOING SELF-EXPANDING TRANSCATHETER AORTIC VALVE REPLACEMENT IN A FAILED SURGICAL VALVE: REAL-WORLD OUTCOMES FROM THE TRANSCATHETER VALVE THERAPY REGISTRY

Author

Allen, Keith B., primary, Chhatriwalla, Adnan, additional, Bapat, Vinayak Nilkanth, additional, Tang, Gilbert Hin-Lung, additional, Grubb, Kendra Janel, additional, Setty, Sampoornima, additional, Berry, Natalia, additional, Zahr, Firas E., additional, Garcia, Santiago, additional, Reardon, Michael J., additional, Webb, John G., additional, Sathananthan, Janarthanan, additional, Vora, Amit N., additional, Eisenberg, Ruth, additional, and Gada, Hemal, additional

Published
2023
Full Text
View/download PDF

40. Structural Valve Deterioration After Self-Expanding Transcatheter or Surgical Aortic Valve Implantation in Patients at Intermediate or High Risk

Author

O’Hair, Daniel, primary, Yakubov, Steven J., additional, Grubb, Kendra J., additional, Oh, Jae K., additional, Ito, Saki, additional, Deeb, G. Michael, additional, Van Mieghem, Nicolas M., additional, Adams, David H., additional, Bajwa, Tanvir, additional, Kleiman, Neal S., additional, Chetcuti, Stanley, additional, Søndergaard, Lars, additional, Gada, Hemal, additional, Mumtaz, Mubashir, additional, Heiser, John, additional, Merhi, William M., additional, Petrossian, George, additional, Robinson, Newell, additional, Tang, Gilbert H. L., additional, Rovin, Joshua D., additional, Little, Stephen H., additional, Jain, Renuka, additional, Verdoliva, Sarah, additional, Hanson, Tim, additional, Li, Shuzhen, additional, Popma, Jeffrey J., additional, and Reardon, Michael J., additional

Published
2023
Full Text
View/download PDF

41. CRT-700.03 TAVR in Intermediate-Risk Patients: 5-Year Outcomes From the SURTAVI Continued Access Study

Author

Mahoney, Paul, primary, Newton, Joseph, additional, Gada, Hemal, additional, Mumtaz, Mubashir, additional, Williams, Mathew, additional, Waksman, Ron, additional, Bafi, Ammar, additional, Fail, Peter, additional, Netherland, Donald, additional, Davis, Thomas, additional, Batra, Sanjay, additional, Chhim, Rothy, additional, Verdoliva, Sarah, additional, and Reardon, Michael J., additional

Published
2023
Full Text
View/download PDF

45. Aortic Annulus S-Curve

Author

Zgheib, Ali, primary, Campens, Laurence, additional, Abualsaud, Ali, additional, Al Isma’ili, Abdullah, additional, Barbanti, Marco, additional, Dvir, Danny, additional, Gada, Hemal, additional, Granada, Juan F., additional, Latib, Azeem, additional, Leipsic, Jonathon, additional, Maisano, Francesco, additional, Martucci, Giuseppe, additional, Medina de Chazal, Horacio A., additional, Modine, Thomas, additional, Mylotte, Darren, additional, Prendergast, Bernard, additional, Sawaya, Fadi, additional, Spaziano, Marco, additional, Tang, Gilbert, additional, Theriault-Lauzier, Pascal, additional, Tchetche, Didier, additional, van Mieghem, Nicolas, additional, Søndergaard, Lars, additional, De Backer, Ole, additional, and Piazza, Nicolo, additional

Published
2022
Full Text
View/download PDF

49. Balloon-Expandable Valve for Treatment of Evolut Valve Failure: Implications on Neo-Skirt Height and Leaflet Overhang

Author

Akodad, Mariama, primary, Sellers, Stephanie, additional, Landes, Uri, additional, Meier, David, additional, Tang, Gilbert H.L., additional, Gada, Hemal, additional, Rogers, Toby, additional, Caskey, Michael, additional, Rutkin, Bruce, additional, Puri, Rishi, additional, Rovin, Joshua, additional, Leipsic, Jonathon, additional, Sondergaard, Lars, additional, Grubb, Kendra J., additional, Gleason, Patrick, additional, Garde, Kshitija, additional, Tadros, Hatem, additional, Teodoru, Sebastian, additional, Wood, David A., additional, Webb, John G., additional, and Sathananthan, Janarthanan, additional

Published
2022
Full Text
View/download PDF

50. Effect of COVID-19 Surveillance Testing on Patient Perceptions in Outpatients Undergoing Cardiovascular Procedures: Results From the Restoring Non-Emergent Cardiovascular Care in the Peri-COVID-19 Era (RECIPE) Registry

Author

Bruening, Stephen, primary, Vora, Amit, additional, Gada, Hemal, additional, Patel, Chinmay, additional, Schmidt, Torrey, additional, Hubbard, C. Randy, additional, Chang, David, additional, Aladham, Ahmed, additional, and Bachinsky, William, additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results